Degasa S.A. De C.V.

Warning LetterOpen

United StatesFEI 3004555163Issued Apr 18, 2018

Source: FDA warning letter records. FDA has not published the text of this letter. To check it, open FDA's record for this establishment, listed under FEI 3004555163.

Letter Details

Firm: Degasa S.A. De C.V.
Location: United States
FEI Number: 3004555163
Country: United States
Issue Date: April 18, 2018
Issuing Office: N/A
Product Type: Other
Status: Open

Summary

Based on limited metadata, this FDA Warning Letter was issued to Degasa S.A. De C.V. on April 18, 2018, regarding a product classified as "Other," though the specific product category and detailed violations are not available in the provided information. Without access to the full letter text or a defined subject line, the exact nature of the regulatory concerns cannot be determined. The issuing office information is also unavailable, limiting visibility into which FDA division initiated this action. Additional documentation would be needed to identify the specific violations and applicable regulatory requirements.